BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 19877154)

  • 1. Genome modification in human embryonic stem cells.
    Tenzen T; Zembowicz F; Cowan CA
    J Cell Physiol; 2010 Feb; 222(2):278-81. PubMed ID: 19877154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem cells: current progress and potential for regenerative medicine.
    Amabile G; Meissner A
    Trends Mol Med; 2009 Feb; 15(2):59-68. PubMed ID: 19162546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient reprogramming of human and mouse primary extra-embryonic cells to pluripotent stem cells.
    Nagata S; Toyoda M; Yamaguchi S; Hirano K; Makino H; Nishino K; Miyagawa Y; Okita H; Kiyokawa N; Nakagawa M; Yamanaka S; Akutsu H; Umezawa A; Tada T
    Genes Cells; 2009 Dec; 14(12):1395-404. PubMed ID: 19912344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic analysis of induced pluripotent stem (iPS) cells: routes to reprogramming.
    Kanawaty A; Henderson J
    Bioessays; 2009 Feb; 31(2):134-8. PubMed ID: 19204985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic gene targeting.
    Yáñez RJ; Porter AC
    Gene Ther; 1998 Feb; 5(2):149-59. PubMed ID: 9578833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors.
    Okada Y; Ueshin Y; Hasuwa H; Takumi K; Okabe M; Ikawa M
    Genesis; 2009 Apr; 47(4):217-23. PubMed ID: 19208434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of medakafish as a model for stem cell-based gene therapy: efficient gene delivery and potential chromosomal integration by baculoviral vectors.
    Yan Y; Du J; Chen T; Yi M; Li M; Wang S; Li CM; Hong Y
    Exp Cell Res; 2009 Aug; 315(13):2322-31. PubMed ID: 19406120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
    Romano G
    Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cells and nuclear reprogramming.
    Saric T; Hescheler J
    Minim Invasive Ther Allied Technol; 2008; 17(2):64-78. PubMed ID: 18465442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and genetic modification of induced pluripotent stem cells.
    Schambach A; Cantz T; Baum C; Cathomen T
    Expert Opin Biol Ther; 2010 Jul; 10(7):1089-103. PubMed ID: 20528610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain- and loss-of-function approaches in the chick embryo.
    Sauka-Spengler T; Barembaum M
    Methods Cell Biol; 2008; 87():237-56. PubMed ID: 18485300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic recombination pathways and their application for genome modification of human embryonic stem cells.
    Nieminen M; Tuuri T; Savilahti H
    Exp Cell Res; 2010 Oct; 316(16):2578-86. PubMed ID: 20542027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
    Sinn PL; Sauter SL; McCray PB
    Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pluripotency: toward a gold standard for human ES and iPS cells.
    Smith KP; Luong MX; Stein GS
    J Cell Physiol; 2009 Jul; 220(1):21-9. PubMed ID: 19326392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of retroviral and lentiviral gene transfer to murine embryonic stem cells.
    Chilton JM; Le Doux JM
    J Biotechnol; 2008 Nov; 138(1-2):42-51. PubMed ID: 18761041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting pluripotency for therapeutic gain.
    Deng W
    Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation tolerance in an age of induced pluripotency.
    Fairchild PJ
    Curr Opin Organ Transplant; 2009 Aug; 14(4):321-5. PubMed ID: 19542888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease models from pluripotent stem cells.
    Lengerke C; Daley GQ
    Ann N Y Acad Sci; 2009 Sep; 1176():191-6. PubMed ID: 19796247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: Stem cells and gene therapy.
    Alenzi FQ; Lotfy M; Tamimi WG; Wyse RK
    Lab Hematol; 2010 Sep; 16(3):53-73. PubMed ID: 20858588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.